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Neuroligins (NLGNs) are cell adhesion molecules that are important for proper synaptic formation and functioning, and are critical
regulators of the balance between neural excitation/inhibition (E/I). Mutations in NLGNs have been linked to psychiatric disorders in
humans involving social dysfunction and are related to similar abnormalities in animal models. Chronic stress increases the likelihood for
affective disorders and has been shown to induce changes in neural structure and function in different brain regions, with the
hippocampus being highly vulnerable to stress. Previous studies have shown evidence of chronic stress-induced changes in the neural E/I
balance in the hippocampus. Therefore, we hypothesized that chronic restraint stress would lead to reduced hippocampal NLGN-2
levels, in association with alterations in social behavior. We found that rats submitted to chronic restraint stress in adulthood display
reduced sociability and increased aggression. This occurs along with a reduction of NLGN-2, but not NLGN-1 expression (as shown with
western blot, immunohistochemistry, and electron microscopy analyses), throughout the hippocampus and detectable in different layers
of the CA1, CA3, and DG subfields. Furthermore, using synthetic peptides that comprise sequences in either NLGN-1 (neurolide-1) or
NLGN-2 (neurolide-2) involved in the interaction with their presynaptic partner neurexin (NRXN)-1, intra-hippocampal administration
of neurolide-2 led also to reduced sociability and increased aggression. These results highlight hippocampal NLGN-2 as a key molecular
substrate regulating social behaviors and underscore NLGNs as promising targets for the development of novel drugs for the treatment
of dysfunctional social behaviors.
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INTRODUCTION
Substantial evidence highlights the synaptic cell adhesion
molecules neuroligins (NLGNs) and neurexins (NRXNs) as
critical regulators of the neural excitation/inhibition (E/I)
balance (Levinson and El-Husseini, 2005; Su¨dhof, 2008).
The trans-synaptic complex formed by postsynaptically
expressed NLGNs with their presynaptic partners, NRXNs,
has been critically implicated in the maintenance and
function of excitatory glutamatergic and inhibitory gamma-
aminobutyric acid (GABA)-ergic synapses (Su¨dhof, 2008).
Among the four members of the NLGN family, NLGN-1
and NLGN-2 are typically associated with either excitatory
(NLGN-1) or inhibitory (NLGN-2) synapses (Graf et al,
2004; Chih et al, 2005).
Alterations in the balance between neural E/I have been
proposed to underlie behavioral dysfunctions in several
psychiatric disorders, such as schizophrenia and autism
spectrum disorders, characterized by marked deficits in
social interactions and communication (Harrison and
Weinberger, 2005; Su¨dhof, 2008). This view is supported
by clinical evidence reporting mutations in genes encoding
for NLGN and NRXNs (Sun et al, 2011; Gauthier et al, 2011).
Furthermore, mice exhibiting mutations in NLGNs were
shown to display alterations in the E/I balance as well as
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abnormal social behaviors (Tabuchi et al, 2007; Hines et al,
2008; Jamain et al, 2008; Blundell et al, 2010).
This genetic evidence is in line with the hypothesis that
pathological social behaviors can emerge from the disrup-
tion in the E/I balance occurring in relevant neural circuits
during critical periods of development (Gogolla et al, 2009).
However, a recent report (Yizhar et al, 2011) showed that the
acute alteration of this balance in adulthood can also have
immediate effects: the acute elevation of the E/I balance in
the prefrontal cortex in mice, by optogenetic facilitation of
glutamatergic activity, was shown to reduce social explora-
tion (Yizhar et al, 2011). These findings raise the possibility
that not only genetic factors, but also life experiences or
treatments alter the expression and/or function of key
molecular pathways that control the levels of excitatory and/
or inhibitory synapses. These changes could underlie
alterations in social behaviors occurring in adulthood.
In rodents, chronic stress is possibly the best character-
ized example of environmentally induced social avoidance
(Toth and Neumann, 2013), and emerging evidence
indicates that it can also increase aggressive behavior
(Wood et al, 2008). Chronic stress has also been shown to
induce changes in neural structure and function in different
brain regions, with the hippocampus being highly vulner-
able to stress (McEwen, 2005). Importantly, in the
hippocampus, chronic stress is thought to lead to an
increase in the E/I balance as indicated by enhanced
synaptic excitation (Karst and Joe¨ls, 2003), increased levels
of glutamate transporters (GLTs) (Reagan et al, 2004), and a
reduced number of parvalbumin-immunoreactive GABA-
ergic interneurons (Hu et al, 2010). A role for cell adhesion
molecules in the structural and functional effects of chronic
restraint stress has been substantiated in studies focusing
on NCAM (and its polysialylated form, PSA-NCAM) and L1
following chronic stress (Sandi, 2004; Bisaz et al, 2011;
Gilabert-Juan et al, 2011). We selected the 3-week chronic
restraint stress paradigm in rats, as it has been shown to
increase aggressive behavior against homecage mates
(Wood et al, 2003, 2008), as well as for its well-characterized
effects in the literature at different levels of analysis,
including morphological, electrophysiological, and molecu-
lar levels, particularly with regards to the hippocampus
(Pavlides et al, 2002; Stewart et al, 2005; Donohue et al,
2006; McEwen, 2012).
In this study, we aimed to investigate whether chronic
stress would lead to changes in the expression levels of
NLGN-1 and NLGN-2 in specific hippocampal subfields in
association with alterations in social behavior (sociability
and aggression). We hypothesized that chronic restraint
stress would lead to reduced hippocampal NLGN-2 levels,
with either increased or unchanged NLGN-1 levels. The
hypothesis regarding NLGN-2 was based on the following
observations: (i) NLGN-2-deficient mice display increased
hippocampal excitability (Jedlicka et al, 2011) and (ii)
reduced ultrasonic vocalizations (Wo¨hr et al, 2012); and
(iii) hippocampus-specific overexpression of NLGN-2 led to
inhibited aggressive behavior (Kohl et al, 2013). Regarding
NLGN-1: (i) the fact that NLGN-1 overexpression leads to
increased synaptic excitation in the hippocampus
(Dahlhaus et al, 2010) led us to speculate that increased
NLGN-1 expression occurs following exposure to chronic
stress; however, (ii) the lack of evidence for alterations in
sociability or aggressive behaviors from genetic studies
manipulating expression levels of this gene led us to
hypothesize a lack of changes in NLGN-1 expression
following chronic stress. Using a combination of behavioral,
biochemical, and morphological approaches, we obtained
results in support of these hypotheses that led us to further
postulate that pharmacological interference with NLGN-2,
but not NLGN-1, function in the hippocampus would alter
social and aggressive behaviors. To investigate this, we
performed a follow-up pharmacological study to determine
the impact of interfering with NLGN function on social
behaviors through intra-hippocampal microinfusion of
synthetic peptides derived from either NLGN-1 (neuro-
lide-1) (Gjrlund et al, 2012) or NLGN-2 (neurolide-2).
MATERIALS AND METHODS
Animals
Animal care procedures were conducted in accordance with
the guidelines set by the European Community Council
Directives (86/609/EEC) and the Cantonal Veterinary
Authorities (Vaud, Switzerland). Male Sprague–Dawley rats
(Charles River Laboratories; Lyon, France) weighing 250 g at
the start of the experiments were pair-housed under light-
(12 h light/dark cycle; lights on at 0700 hours) and
temperature (22±2 1C)-controlled conditions. Food and
water were freely available. With the exception of the
resident–intruder test (performed from 0800–2000 hours),
all experiments were conducted between 0830 and 1400
hours to minimize the influence of hormonal fluctuations.
All animals were handled for 2 min/day for the 3 d preceding
the first behavioral test or surgery. The animals used for
western blot, immunohistochemistry, or electron
microscopy analyses were killed 1 day after stress.
Chronic Restraint Stress
Rats were carefully wrapped in cloth to prevent injuries from
the restraint. Animals were restrained 6 h/day for 21 days in
wire mesh restrainers (26 26 cm) in their homecage
between 1000 and 1600 hours. Body weight was measured
every other day during the stress protocol starting at day 1.
There was no indication of wounds or injuries to the rats.
Social Behaviors
The following tests were applied to evaluate different aspects
of social behaviors: the three-chambered social approach, the
resident–intruder, and the social encounter in a neutral cage
tests. All behaviors were scored by a behavioral expert
blinded to experimental conditions. The social approach test
was performed 1 day after the stress paradigm and was
performed to evaluate the animals’ preference to approach a
juvenile conspecific or an object (see Supplementary
Materials and Methods for further details). Two weeks after
the social approach, test animals were tested for aggression
in the resident–intruder test. The effect of intra-hippocampal
infusion of neurolide-1 and/or neurolide-2 on social
behavior was assessed in the social approach test and the
social encounter in a neutral cage test (see Supplementary
Materials and Methods for further details).
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Western Blots
Protein analyses were performed to investigate NLGN
expression in the synaptoneurosomal compartments and
total homogenates from hippocampal CA1, CA3, and DG
and also in the frontal cortex as control region (see
Supplementary Figure S1, Supplementary Figure S2 and
Supplementary Materials and Methods for further details
and for validation of the NLGN-2 antibody).
Immunohistochemistry
Immunofluorescent staining against NLGN-2 allowed for a
detailed analysis of the protein in subregions of the
hippocampal CA1, CA3, and DG (see Supplementary
Materials and Methods for further details). We found that
NLGN-2 colocalized with gephyrin that was expected, as
both are expressed at GABA-ergic neurons. Furthermore,
omission of the primary antibody or incubation of the
primary antibody with a specific NLGN-2-blocking peptide
prevented a NLGN-2 signal (Supplementary Figure S3).
Electron Microscopy Analyses
Electron microscopy enabled us to visualize and analyze
ImmunoGold-positive labeling for NLGN-2 in the hippo-
campus (see Supplementary Materials and Methods for
further details).
Measurement of Hippocampal Volume
Measurements of the volume of the whole hippocampus
were made using the Cavalieri principle (Sousa et al, 1997;
Popov et al, 2004, see Supplementary Materials and
Methods for further details).
The NLGN-Derived Peptides, Neurolide-1, and
Neurolide-2
The neurolide-1 peptide (SEGNRWSNSTKGLFQRA) was
previously described and validated (Gjrlund et al, 2012).
The neurolide-2 peptide (HSEGLFQRA) was newly devel-
oped for the current study. As no NLGN-2-derived peptide
was available, we developed neurolide-2. Although there is
no structural data for the NLGN-2/NRXN-1 complex, the
ectodomain of NLGN-2 shares 470% sequence identity
with the ectodomain of NLGN-1 (Gjrlund et al, 2012), and
the crystal structure of the extracellular cholinesterase-like
domain from NLGN-2 has been solved (Koehnke et al,
2008). Thus, we designed the neurolide-2 peptide based on
sequence and structure homology between homologs
sequence motifs in NLGN-2 and NLGN-1, respectively
(Figure 4a–c), assuming that if the neurolide-1 motif is
involved in NLGN-1 interaction with NRXN-1b (Gjrlund
et al,, 2012), so it might be the neurolide-2 motif. The
difference between these two motifs is that neurolide-1
includes a sequence corresponding to splice site B in NLGN-
1, which increases affinity of the protein to NRXN-1b
binding. Splice site B is absent in NLGN-2. Thus, the
difference between the sequences of neurolide-2 and
neurolide-1 reflects the fundamental difference in structural
(and therefore functional) modifications between NLGN-2
and NLGN-1.
The neurolide-2 peptide (HSEGLFQRA) was synthesized
as a tetramer composed of four monomers coupled to a
lysine backbone. Scrambled versions (FRGEASLQH, QAS-
FELRHG, and FEASHRLQG) and reversed form (ARQFL-
GESH) of 2NLGN2d peptide were synthesized in the same
way by Schafer-N (Copenhagen, Denmark). The peptides
were synthesized using the solid-phase Fmoc protection
strategy, and purity was estimated to be X80% by high-
performance liquid chromatography. The peptides were
reconstituted in sterile distilled water, and the concentra-
tions were determined by measuring the absorbance at
205 nm. Human recombinant NLGN-2 was obtained from
R&D Systems (Abingdon, UK).
The concentration for the in vitro assay for neurite
outgrowth and for the in vivo microinfusion experiments
were selected based on a cell survival assay (see
Supplementary Materials and Methods for further details
on neurolide-1, as well as Supplementary Figure S4).
Neurite Outgrowth
Hippocampal neurons were obtained on embryonic day 19
from Wistar rat embryos (Charles River Laboratories,
Kisselegg, Germany) as described previously (Kraev et al,
2011). Neurite outgrowth was determined as previously
described (Kolkova et al, 2000) (see Supplementary
Materials and Methods for further details).
Plasma Corticosterone Analyses
Plasma samples (dilution 1/40) were assayed by a commer-
cially available enzyme-linked immunoabsorbent assay
(Corticosterone EIA Kit, Enzo Life Sciences, Lausen,
Switzerland). The intra-assay coefficient of variation was
8% and 6.6% for low- and high concentrations, respectively.
The inter-assay coefficient of variation was 13.1% and 7.8%
for low- and high concentrations, respectively.
Surgery and Pharmacological Infusions
Rats subjected to pharmacological experiments were
bilaterally implanted with 5-mm stainless steel guide
cannulae (Plastics One, Roanoke, VA, USA) aimed at the
dorsal hippocampus Bilateral simultaneous microinfusions
of either the NLGN-1-derived peptide, termed neurolide-1
(Gjrlund et al, 2012), or the NLGN-2-derived peptide,
termed neurolide-2 (dose for each peptide: 2.5 mg in 1 ml
vehicle) were delivered at 0.5 ml/min over 2 min. The
injector remained in place for 1 min additionally to allow
local drug diffusion. Animals were infused once per day
over 5 consecutive days before behavioral experiments.
Thereafter, animals were killed by i.p. pentobarbital
injection, and correct cannulae placement was verified with
Evans blue and histology (see Supplementary Materials and
Methods for further details).
Open-Field and Morris Water Maze
To investigate the specificity of intra-hippocampal neuro-
lide-2 infusion on social behaviors, we assessed animals’
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behavior after neurolide-2 infusion in the open-field
(anxiety and locomotion) and Morris water maze (cognitive
integrity). For methodological details see Supplementary
Materials and Methods.
Statistical Analysis
Data are expressed as the mean±SE. Behavioral observa-
tions from the social approach test and corticosterone data
were analyzed using a two-way repeated measures (RM)
analysis of variance (ANOVA) (Yang et al, 2011) followed
by Bonferroni post hoc tests where appropriate. The in vitro
data were analyzed using one-way RM ANOVA followed by
the Bonferroni post hoc tests where appropriate. Two-
sample comparisons were analyzed using the two-tailed
Student’s t-test. Data were considered statistically signifi-
cant when po0.05.
RESULTS
Chronic Stress Reduces Social Investigation and
Increases Aggressive Behavior
Body weight gain was reduced by chronic stress (data not
shown), confirming the stressful nature of the restraint
protocol. In addition, stress affected exploration in the
social approach task (two-way RM ANOVA, main effect of
stress F1,26¼ 7.35, p¼ 0.01, controls: n¼ 15, stressed:
n¼ 13, Figure 1a). Post hoc tests showed that stress reduced
investigation of the juvenile (t¼ 4.16, po0.001) but not the
object (t¼ 0.31, p40.05). Locomotor activity did not differ
between controls and stressed animals (Figure 1b; t¼ 0.94,
df¼ 25, p¼ 0.36). The same rats were tested in the resident–
intruder test 14 days afterwards. Resident rats that had
experienced chronic stress were overly aggressive against
their matched intruder as compared with control residents
(Figure 1c; t¼ 2.43, df¼ 25, p¼ 0.02). The enhanced
aggression exhibited by stressed animals is reflected by
the components that comprise total offensive behavior
(Figure 1d–f; offensive upright: t¼ 2.88, df¼ 25, p¼ 0.008;
keeping down: t¼ 2.27, df¼ 25, p¼ 0.03; and a nonsignifi-
cant tendency for lateral threat: t¼ 1.59, df¼ 25, p¼ 0.12).
Moreover, stressed rats tended to bite their opponent more
often than controls (Figure 1g; control: 2.8±1.0; stressed:
5.7±1.2; t¼ 1.88, df¼ 25, p¼ 0.07).
Chronic Stress Leads to Decreased Expression of
NLGN-2 Throughout the Hippocampus
Western blot analyses from synaptoneurosomal fractions
indicated a reduction in NLGN-2, but not NLGN-1, protein
levels throughout the different hippocampal subfields CA1
(NLGN-1: t¼ 0.92, df¼ 10, p¼ 0.38 n¼ 6/group, Figure 2a;
NLGN-2: t¼ 2.48, df¼ 10, p¼ 0.03, n¼ 6/group, Figure 2e),
CA3 (NLGN-1: t¼ 0.67, df¼ 9, p¼ 0.52, control: n¼ 5,
stress: n¼ 6, Figure 2b; NLGN-2: t¼ 2.48, df¼ 9, p¼ 0.035,
control: n¼ 6, stress: n¼ 5, Figure 2f) and DG (NLGN-1:
t¼ 0.08, df¼ 16, p¼ 0.94, n¼ 9/group, Figure 2c; NLGN-2:
t¼ 3.34, df¼ 10, p¼ 0.007, n¼ 6/group, Figure 2g). The
chronic stress-induced downregulation of NLGN-2 was
specific to the hippocampus, as we found that stress did
not affect expression of NLGN-2 (or NLGN-1) in the frontal
cortex (NLGN-1: t¼ 0.45, df¼ 9, p¼ 0.67, control: n¼ 6,
stress: n¼ 5, Figure 2d; NLGN-2: t¼ 0.81, df¼ 10, p¼ 0.44,
n¼ 6/group, Figure 2h). Furthermore, expression levels of
NLGN-1 and NLGN-2 in the total fraction from hippocam-
pus or frontal cortex were not affected by stress (Supple-
mentary Figure S2). Validation of the NLGN-2 antibody
for the western blot and immunohistochemical analyses
is presented in Supplementary Figure S1 and S3.
Reduced levels of hippocampal NLGN-2 in chronic stress-
treated animals were confirmed by immunohistochemistry
as described below. We found reduced NLGN-2 expression
in different layers throughout the CA1 (stratum oriens,
t¼ 1.04, df¼ 6, p¼ 0.34; stratum pyramidale: t¼ 0.57,
df¼ 6, p¼ 0.59, stratum radiatum, t¼ 2.46, df¼ 6,
p¼ 0.049; stratum lacunosum-moleculare: t¼ 2.84, d¼ 6,
p¼ 0.03, Figure 3a), CA3 (stratum oriens, t¼ 3.12, df¼ 6,
p¼ 0.02; stratum pyramidale: t¼ 2.64, df¼ 6, p¼ 0.04;
stratum radiatum: t¼ 2.63, df¼ 6, p¼ 0.04; stratum lacu-
nosum-moleculare: t¼ 1.60, df¼ 6, p¼ 0.16, Figure 3b), and
DG (granular cell layer: t¼ 2.81, df¼ 6, p¼ 0.03; molecular
cell layer: t¼ 2.32, df¼ 6, p¼ 0.06, Figure 3c).
Using electron microscopy, we were able to confirm
that the density of total hippocampal NLGN-2 was reduced
in stressed animals as compared with controls (t¼ 2.52,
df¼ 6, p¼ 0.045, Figure 3d). An example of ImmunoGold-
labeled particles for NLGN-2 is shown at an inhibitory
synapse (Figure 3e). We found that total hippocampal
volume was not affected by stress (t¼ 0.48, df¼ 14, p¼ 0.64,
Figure 3f).
In Vitro Characterization of the NLGN-2-Derived
Peptide: Effects on Neurite Outgrowth
As the only existing and characterizing peptide was
neurolide-1 peptide (Gjrlund et al, 2012), we developed
here the neurolide-2 peptide based on sequence and
structure homology between homologs sequence motifs in
NLGN-2 and NLGN-1, respectively (Figure 4a–c). For its
validation, we first performed an in vitro study in
primary hippocampal cell cultures to check different
peptide concentrations in cell survival (see Supplementary
Materials and Methods and Supplementary Figure S4). We,
then, proceeded to assess the effect of neurolide-2 in neurite
outgrowth in hippocampal neurons. A treatment effect on
neurite outgrowth was observed (one-way RM ANOVA,
po0.0001) only with neurolide-2 (t¼ 4.36, po0.01;
Figure 4d). The neuritogenic effect of neurolide-2, as well
as of the whole NLGN-2 ectodomain, was abrogated
by knocking down NRXN-1b (Figure 4e–f), indicating
that in single-neuronal cultures, neuritogenic activity
of the peptide required NRXN-1b expression, and that
the neurolide-2 peptide might have a potential to interfere
with NLGN-2-NRXN-1b binding. This result shows that the
peptide is biologically active and, accordingly, potentially
effective to disrupt NLGN-2-NRXN-1b interactions.
Infusion of a NLGN-2-, but not NLGN-1-, Derived
Peptide into the Hippocampus Leads to Reduced Social
Investigation and Increased Aggression
First, we found that infusion of neurolide-1 in the
hippocampus did not affect social investigation (two-way
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RM ANOVA, main treatment effect, F1,10¼ 0.02, p¼ 0.88,
n¼ 6/group, Figure 5a). However, neurolide-2 infusion did
reduce social investigation as compared with vehicle-treated
animals (two-way RM ANOVA, main treatment effect,
F1,17¼ 4.65, p¼ 0.046. post hoc tests: po0.01, vehicle:
n¼ 6 and neurolide-2: n¼ 7, Figure 5b). None of the
peptides affected overall locomotor activity (neurolide-1:
t¼ 0.55, df¼ 12, p¼ 0.59, n¼ 7 and neurolide-2: t¼ 0.53,
df¼ 10, p¼ 0.61, n¼ 6, Figure 5c).
Neurolide-2 treatment led to increased aggressive beha-
vior when animals (n¼ 7/group) were exposed to an
unfamiliar male in a neutral cage (t¼ 2.66, df¼ 12,
p¼ 0.02, Figure 5d). In line with the results on stressed
animals in the resident–intruder task, animals treated with
neurolide-2 tended to show increased amounts of offensive
upright (t¼ 1.70, df¼ 12, p¼ 0.12, Figure 5e), keeping down
(t¼ 2.17, df¼ 12, p¼ 0.05, Figure 5f), although the duration
of lateral threat was low and not different between the two
groups (t¼ 0.28, df¼ 12, p¼ 0.78, Figure 5g). The infusion
of neurolide-2 into the hippocampus did not affect
peripheral corticosterone levels either at baseline or
immediate after the social encounter (two-way RM ANOVA,
main effect of social encounter, F1,39¼ 42.6, po0.001, but
no effect of drug, F1,39¼ 0, p¼ 0.97, n¼ 13 for vehicle/
homecage and n¼ 10 for all other groups, Figure 5h).
Importantly, the effectiveness of neurolide-2 hippocampal
treatment seems to be quite specific for social behaviors, as
in the open field we found that locomotor activity or
anxiety-like behavior were unaffected (locomotor activity:
t¼ 0.44, df¼ 11, p¼ 0.67 and anxiety-like behavior: t¼ 1.49,
df¼ 11, p¼ 0.16, vehicle: n¼ 6, neurolide-2: n¼ 7) (see
Supplementary Figure S5). Moreover, spatial learning in the
water maze was also not affected by neurolide-2 infusion
(Supplementary Figure S6).
DISCUSSION
This study shows that chronic restraint stress in
adult rats leads to reduced sociability and increased
aggression along with a reduction of NLGN-2, but not
NLGN-1, expression throughout the hippocampus that
was detectable in different layers of the CA1, CA3, and
DG subfields. The decrease in NLGN-2 was specific to
the synaptoneurosomal compartment, as NLGN-2 protein
levels were not affected in the total fraction. These
results led us to speculate that interfering with NLGN-2
function in the hippocampus of adult rats would affect
social behaviors.
Using synthetic peptides that comprise sequences in
either NLGN-1 (neurolide-1) or NLGN-2 (neurolide-2)
involved in the interaction with their presynaptic partner
NRXN-1 (Gjrlund et al, 2012), we found that intra-
hippocampal administration (over 5 consecutive days) of
neurolide-2 in adult rats reduced sociability and increased
aggression. Together with our previous findings showing
that viral-induced overexpression of NLGN-2 in the adult
hippocampus leads to decreased aggression (Kohl et al,
2013), these results highlight hippocampal NLGN-2 as a key
molecular substrate regulating social behaviors. In an
earlier study, however, constitutive NLGN-2 knockout mice
did not differ from controls in social interactions (Blundell
et al, 2009). We suspect that during development,
compensatory mechanisms are at work in the NLGN-2
Figure 1 Effects of chronic restraint stress on sociability and aggressive behavior. Investigatory behavior for a juvenile and an object
(***po0.001, controls: n¼ 15, stressed: n¼ 13 (a). Locomotor activity during the social approach task (b). Total aggressive behavior expressed
in the resident–intruder test (*po0.05) (c); offensive upright (**po0.01) (d); keeping down (*po0.05) (e); lateral threat (f) and biting (g). White bars
indicate controls whereas the black bars indicate stressed animals. Error bars represent SEM.
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knockout mice that may have masked the expression of the
social impairments in these animals.
The reduction in social exploration observed following
exposure to chronic stress was not because of a general
decrease in locomotor activity, which is in agreement with
the literature (Kleen et al, 2006). These results are in line
with the finding of social avoidance in rats exposed to
a mild chronic stress protocol of the same length as here
(21 days) (Kompagne et al, 2008) and with mounting
evidence indicating reduced sociability following sustained
exposure to stress (Toth and Neumann, 2013). The
increased aggression that we find in stressed animals
in a resident–intruder test extends previous reports,
indicating increased aggression toward homecage mates
(Wood et al, 2008).
The mechanisms whereby chronic restraint stress alters
individuals’ social interactions are probably multiple.
Chronic restraint stress is known to induce neural
remodeling in several brain regions, notably including the
hippocampus, but also the prefrontal cortex and amygdala
(Leuner and Shors, 2012; McEwen, 2012). A growing body
of evidence suggests that the hippocampus is critically
involved in the regulation of social interactions (Kogan
et al, 2000; Uekita and Okanoya, 2011) and aggressive
behaviors (Maaswinkel et al, 1997; Uekita and Okanoya,
2011). In agreement with the literature (Lee et al, 2009), we
found evidence for a marginal (2.2%), and nonsignificant
reduction in hippocampal volume in chronically stressed
rats. Importantly, chronic stress is known to induce neural
remodeling, including dendritic atropy and changes in
synaptic morphology, throughout the hippocampus (Sousa
et al, 2000; Bessa et al, 2009; Stewart et al, 2005; Donohue
et al, 2006; McEwen, 2012).
Substantial evidence highlights changes in the neural
circuit E/I balance as an underlying mechanism for social
dysfunction (Harrison and Weinberger, 2005; Su¨dhof,
2008). Importantly, different lines of evidence indicate that
chronic stress might lead to an increase in the E/I balance in
the hippocampus. In particular, chronic stress was shown
(i) to enhance glutamate transmission and synaptic excita-
tion in different hippocampal subfields (Karst and
Joe¨ls, 2003; Joe¨ls et al, 2004); (ii) to increase expression
levels of the GLTs-1 and -1b (Reagan et al, 2004) and
synaptobrevin/vesicle-associated membrane protein 2, a
synaptic vesicle molecule involved in neurotransmitter—
notably glutamate—release (Gao et al, 2006); and (iii)
chronic stress was also shown to lead to a reduction in
extracellular GABA levels (Grnli et al, 2007), as well as in
the number of parvalbumin-immunoreactive GABA-ergic
interneurons (Hu et al, 2010).
Figure 2 Effects of chronic restraint stress on hippocampal protein neuroligin-1 (NLGN-1) and neuroligin-2 (NLGN-2) expression. Synaptoneurosomal
protein fractions of NLGN-1 (a–d) and NLGN-2 (e–h) in the hippocampal CA1 (a and e), (n¼ 6/group); CA3 (b and f), (n¼ 5–6/group); dentate gyrus
(c and g), (n¼ 9/group); and in the frontal cortex (d and h), (n¼ 5–6/group) (*po0.05, **po0.01). Error bars represent SEM.
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Altogether, these observations provide a picture of
changes in the glutamatergic and GABA-ergic systems indu-
ced by chronic (restraint, in most cases) stress that, along
with the electrophysiological evidence indicated above,
strongly indicate a shift in the balance of the hippocampal
E/I ratio toward increased excitation. Our findings showing
a decreased expression of NLGN-2 throughout the hippo-
campus are congruent with an increased E/I ratio in
stressed animals. However, given the numerous examples
of stress-induced glutamatergic changes (see above), the
fact that no changes were observed in the expression levels
of NLGN-1 raises several questions. One possibility is that
the role of this isoform in the reorganization of the
glutamatergic changes induced by chronic stress occurs at
earlier time points, which are not captured by this study.
Alternatively, NLGN-1 might not be involved with, instead,
other mechanisms being responsible. One interesting
candidate is NLGN-3, as it has been implicated in both
glutamatergic and GABA-ergic synapses (Budreck and
Scheiffele, 2007). Non-synapse-specific mechanisms, such
as the described stress-induced changes in glial glutamate
transporters (Reagan et al, 2004), could also be involved.
Nevertheless, the observed reduction in NLGN-2 expression
might be sufficient to account for the described changes in
the E/I balance. In support of this view is the fact that
whereas the overexpression of NLGN-2 was found to
increase synaptic contacts and shifted the E/I balance
downwards, overexpression of NLGN-1 did not affect these
parameters (Hines et al, 2008).
The reduction that we find in NLGN-2 following chronic
stress was detected both in synaptoneurosomes, in electron
microscope images, and also in immunohistochemical
preparations that revealed the widespread reduction
throughout the different hippocampal subfields and layers
(except for stratum oriens and stratum pyramidale in CA1
and stratum lacunosum-moleculare in CA3). Several studies
have reported structural (Donohue et al, 2006) and
molecular (Reagan et al, 2004; Gao et al, 2006) changes
coinciding with the same subregions where we detect
differences in NLGN-2 expression. However, it is notable
that NLGN-2 was unaltered in the stratum lacunosum-
moleculare of the CA3, one of the layers to which the distal
apical dendritic trees of the pyramidal neurons project and
where stress-induced atrophy is detected (Magarin˜os and
McEwen, 1995).
Therefore, our results illustrate that a life experience,
such as chronic stress, known to elevate the hippocampal
E/I ratio, leads simultaneously to a reduction in NLGN-2
expression throughout the hippocampus and to alterations
in social behaviors. Yizhar et al, (2011) showed
that elevating this ratio in the prefrontal cortex can
induce immediate deficits in sociability. Importantly, our
Figure 3 Effects of chronic restraint stress on hippocampal neuroligin-2 (NLGN-2) expression in the hippocampus as revealed by immunofluo-
rescence and electron microscopy. Immunofluorescence staining for NLGN-2 was employed to investigate the effects of chronic stress in subregions
of the hippocampal CA1 (a); CA3 (b); and dentate gyrus (*po0.05) (c). Hippocampal NLGN-2 density is measured by electron microscopy
(*po0.05) (d). ImmunoGold labeling (as indicated by arrowheads, see insert) for NLGN-2 at an inhibitory synapse (D), dendrite, PrB, presynaptic
bouton, and the scale bar measures 0.5 mm) (e). Total hippocampal volume in controls and stressed animals (f) (n¼ 4/group). Error bars represent
SEM.
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pharmacological experiments showing that intra-hippo-
campal infusions of the synthetic peptide neurolide-2, but
not neurolide-1, lead to similar social alterations as found
following chronic restrain stress. This further supports a
role for hippocampal NLGN-2 in the regulation of social
behaviors (Kohl et al, 2013). These peptides are biologically
active, as shown by their ability to stimulate neurite
outgrowth in dissociated neuronal cultures, when NLGNs
are not involved in trans-synaptic binding with NRXN. Our
findings showing increased aggression following stress
when reduced NLGN-2 expression is observed as well as
following the infusion of neurolide-2, which is in fact a
synthetic fragment of the NLGN-2 molecule, might appear
counterintuitive. However, it is important to emphasize
that the neurolide-2 peptide was designed to coincide with
the exact sequence motifs in NLGN-2 that are involved in
the interaction with NRXN-1b (see Figure 4), thus not
being a full mimetic of the entire NLGN-2 protein. For
example, neurolide-2 lacks critical sequences in the
NLGN-2 part in interaction with the plasma membrane
and intracellular compartment. As proposed for other
synthetic peptides targeting specific cell adhesion mole-
cules (Foley et al, 2000; Cambon et al, 2003; Kraev et al,
2011), when given in vivo, these peptides can disrupt
endogenous cell–cell molecular interactions and eventually
display antagonistic effects. In this case, NRXN-NLGN
complexes for the specific NLGNs were targeted. Therefore,
our data on NLGN-2 reduction following chronic stress and
neurolide-2 infusions seems to be congruent in suggesting
that impaired NLGN-2 function in the hippocampus is
associated with increased aggression. Importantly, we also
showed here that the NLGN-derived peptides neither
altered locomotor activity, anxiety-like behaviors, or
spatial learning nor affected basal or activated plasma
corticosterone responses, thereby excluding non-specific
stress effects in the observed results on social behaviors
obtained with neurolide-2.
Our study highlights for the first time NLGN-2 as a
molecular target broadly affected by chronic stress exposure
in the hippocampus, and suggests that impaired hippo-
campal NLGN-2 function might be instrumental in the
development of alterations in sociability and aggression. In
addition to emphasizing the role of NLGN-2 in the
hippocampus (Kohl et al, 2013), these findings add to a
growing body of data highlighting NLGN-2 in the regulation
of social behaviors (Hines et al, 2008; Wo¨hr et al, 2012).
The effectiveness of neurolide-2 to affect social beha-
viors underscores NLGNs as promising targets for the
Figure 4 Design of Neurolide-2, a neuroligin-2 (NLGN-2)-derived peptide. Model of NLGN-2 (PDB identification 3BL8) (a). Localization of the
neurolide-2 sequence motif is shown in red. Localization of splice site A is shown in blue. (b) Model of the NLGN-1 (green)/neurexin (NRXN)-1b (gray)
complex (PDB identification 3VKF). Localization of part of the neurolide-1 sequence motif (without splice site B) is shown in red. Localization of splice site A
is shown in blue. (c) Sequence motif of neurolide-2 is shown in red (top, UniProtKB/Swiss-Prot identification Q69ZK9). Sequence motif of neurolide-1
(bottom, UniProtKB/Swiss-Prot identification Q62765 is shown in red. It includes splice site B (brown). The in vitro effects of neurolide-2 on neurite
outgrowth as compared with the reversed, or a scrambled sequence (d). Shown is the effect of neurexin (NRXN)-knockdown on neurolide-2- and NLGN-
2 protein-induced neurite outgrowth (*po0.05, **po0.01) (e and f). Error bars represent SEM.
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development of novel drugs ideally capable of improving
social behaviors.
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